Oral Semaglutide Lowers Risk of MACE 14% in High-Risk Adults: Final Phase 3 SOUL Trial Readout
The results seen with the only oral GLP-1 receptor agonist reflect "a profound clinical impact" for adults at high risk for MACE who are averse to injectable therapy.
FDA Authorizes Marketing of First At-Home Test for Chlamydia, Gonorrhea, Trichomoniasis
The Women’s Sexual Health Test (Visby Medical) delivers results in approximately 30 minutes using a vaginal swab.
Dupilumab is Safe and Effective Across Pediatric Populations with Severe Atopic Dermatitis: New Meta-Analysis
Dupilumab significantly improved measures of severe AD, including EASI and IGA, as well as pruritis in pediatric populations aged 6 months to 18 years vs placebo.
CagriSema Achieves Significant Weight Loss in Phase 3 Trial: Daily Dose
Your daily dose of the clinical news you may have missed.
New Study Suggests Bacterial Vaginosis May be Sexually Transmitted
New research shows that treating both men and women with topical and oral antibiotics lowers the odds of bacterial vaginosis recurrence by more than half.
Women's Heart Health: 5 Studies from ACC.25
The risks to women's CV health differ, often significantly, from those faced by men, as demonstrated by 5 abstracts from the American College of Cardiology 2025 annual meeting.
Cleveland Clinic Researchers Develop Risk-Prediction Model for Early-Onset Colorectal Cancer in Young Adults
The model identified BMI, tobacco use, and family history of CRC as the strongest predictors for advanced neoplasia in young adults.
Pediatric Fentanyl Poisonings Spiral Up 1,200% Over 8 Years, Study Finds
In the pediatric population aged 0 to 19 years, exposure to fentanyl was through intentional use by two-thirds, investigators found.
Omalizumab Beats OIT in First Head-to-Head Multi-Food Allergy Trial: Daily Dose
April Issue of Patient Care Digital Edition is Now Live
The April issue covers atopic dermatitis, highlighting primary care’s role in early diagnosis, key updates from recent conferences, and more.
Decline in Smoking Averted Nearly 4 Million Lung Cancer Deaths in the US, Study Estimates
The number of lung cancer deaths averted represents more than 51% of the expected reduction in total cancer deaths, researchers reported.
Omnipod 5 System Leads to Significant Glycemic Improvements After Direct Transition from MDI Insulin with CGM
Mean reduction in HbA1c was nearly 1% after transition from MDI plus CGM to Omnipod 5 in the first randomized trial to evaluate the shift in mode of insulin delivery.
For Sleep Disturbance in Alzheimer Disease, Cannabinoid-Based IGC-AD1 Shines in Phase 2
Depression, Anxiety Underrecognized and Undertreated in COPD, Increasing Disease Burden
A new analysis reveals significant gaps in diagnosis of and treatment for psychiatric disorders in adults with COPD and calls for larger, longitudinal studies.
Better CV Health Tied to Lower Neurodegeneration Risk: Daily Dose
Underutilization of Guideline-Recommended Epinephrine in Anaphylaxis Management: New Study
A 5-year study conducted in Germany showed only 7% of adults and 8% of children with severe anaphylaxis received epinephrine.
UK Research Collaborative Will Evaluate GSK Shingles Vaccine Effect on Dementia
GSK is partnering with the UK Dementia Research Institute and Health Data Research UK to further investigate the potential for the RZV vaccine to mitigate cognitive decline.
Sanofi's Chlamydia Vaccine Granted FDA Fast Track Designation
The FDA granted fast track designation to Sanofi’s chlamydia vaccine candidate today, aiming to prevent infections and address an unmet public health need.
Long COVID's Long Road: A Year 5 Update with Noah Greenspan DPT, PT, CCS, EMT-B
Five years after the COVID-19 pandemic was declared, the protean syndrome dubbed long COVID continues to affect millions; Greenspan is dedicated to helping.
Viking Therapeutics Completes Enrollment for Phase 2 Trial of Oral Obesity Tablet
Data from the phase 2 VENTURE-Oral Dosing Trial of VK2735 is expected in the second half of the year, the company said.
